YR0021
Human SIRPA Alpha Monoclonal Antibody
Größe
£268.00
- SKU:
- YR0021
- Zusätzliche Namen:
- BIT|CD172A|MFR|MYD-1|P84|PTPNS1|SHPS1|SIRP|SIRPA
- Anwendung:
- ELISA, FuncS, Neutralisation
- Molekulargewicht:
- 150 kDa
- Reinheit:
- >95%
- Lagerbedingungen:
- 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- Abclonal
- Immunogen:
- SIRPα
- Formulierung:
- Purified from cell culture supernatant in an animal-free facility
- Uniprot:
- P78324
- Synonyme:
- BIT;Brain Ig-like molecule with tyrosine-based activation motifs;brain-immunoglobulin-like molecule with tyrosine-based activation motifs;CD172 antigen-like family member A;CD172A;inhibitory receptor SHPS-1;macrophage fusion receptor;MFR;MYD-1;myd-1 antigen;P84;PTPNS1;SHPS1;Signal-regulatory protein alpha-1;Signal-regulatory protein alpha-2;Signal-regulatory protein alpha-3;SIRP;tyrosine phosphatase SHP substrate 1;tyrosine-protein phosphatase non-receptor type substrate 1
- Weitere Details:
- Anzurstobart (CC-95251; BMS-986351) is a high-affinity, fully human monoclonal anti-SIRPA Alpha antibody that blocks the binding of CD47 to SIRPA Alpha. Anzurstobart enhances macrophage phagocytic activity against DLBCL cell lines in co-culture models when combined with the antibody Rituximab (HY-P9913). Anzurstobart has the potential for solid and hematologic malignancies research.
- Versandbedingungen:
- Blue Ice